![First Medication to Treat Friedreich's Ataxia Approved on Rare Disease Day! – ERN-RND | European Reference Network on Rare Neurological Diseases First Medication to Treat Friedreich's Ataxia Approved on Rare Disease Day! – ERN-RND | European Reference Network on Rare Neurological Diseases](https://www.ern-rnd.eu/wp-content/uploads/2023/03/FqGY0mpWIAYaZCE-1200x1200.jpg)
First Medication to Treat Friedreich's Ataxia Approved on Rare Disease Day! – ERN-RND | European Reference Network on Rare Neurological Diseases
![Press Release Service: Vesigen Therapeutics Awarded Grant from Friedreich's Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy - CRISPR Medicine Press Release Service: Vesigen Therapeutics Awarded Grant from Friedreich's Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy - CRISPR Medicine](https://mms.businesswire.com/media/20230314005176/en/1736899/5/Vesigen-Brand-Logo-FullColor.jpg)
Press Release Service: Vesigen Therapeutics Awarded Grant from Friedreich's Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy - CRISPR Medicine
![Salem Oaks and The Friedreich's Ataxia Research Alliance Are Partnering on Course on Clinical Trial Protocols - Salem Oaks Salem Oaks and The Friedreich's Ataxia Research Alliance Are Partnering on Course on Clinical Trial Protocols - Salem Oaks](http://salemoaks.com/wp-content/uploads/2020/01/unnamed-file.png)
Salem Oaks and The Friedreich's Ataxia Research Alliance Are Partnering on Course on Clinical Trial Protocols - Salem Oaks
![Information en provenance de Friedreich's Ataxia Research Alliance (FARA) - Association Française Ataxie de Friedreich Information en provenance de Friedreich's Ataxia Research Alliance (FARA) - Association Française Ataxie de Friedreich](https://www.afaf.asso.fr/wp-content/uploads/2022/12/NEWS_actualite-scientifiques-300x200.png)